Jpmorgan Chase & CO Compass Pathways PLC Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Compass Pathways PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 72 shares of CMPS stock, worth $614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72
Previous 72
-0.0%
Holding current value
$614
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CMPS
# of Institutions
134Shares Held
27.5MCall Options Held
108KPut Options Held
172K-
Tcg Crossover Management, LLC Palo Alto, CA3.86MShares$32.9 Million3.47% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.86MShares$32.9 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.23MShares$27.5 Million0.01% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.39MShares$20.4 Million0.77% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.16MShares$18.5 Million0.13% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...